-
-
Recent Posts
- Coronavirus today and the SCI community tomorrow
- Stroke Drug Boosts Stem Cell Therapy For Spinal Cord Injury In Rats
- An integrated in silico pipeline identifies a novel TF combination that promotes enhanced CST growth following injury
- Spike timing-dependent plasticity in the adult rat with chronic cervical spinal cord contusion
- Effect of PTEN antagonist peptide on the functional motor recovery in rat
- GDF10 promotes axonal regeneration and functional recovery: A novel gene therapy strategy for spinal cord injury
- GTX Medical and NeuroRecovery Technologies to merge
- Candidate Therapy From Quebec for Chronic SCI Being Developed in Parallel by Academics and Companies in Switzerland and the Netherlands
- Moving beyond the glial scar for spinal cord repair
- The Struggle to Make CNS Axons Regenerate: Why Has It Been so Difficult?
- The potential of electric field for promoting neurite guidance in spinal cord injury regeneration strategies
- Extraction and selective activation of muscle synergies through spinal stimulation for SCI
- Early limb unloading elicits long-term motor deficits involving motorneuron hyperexcitability associated with persistent alterations in glutamatergic synaptic plasticity in spinal cord injury
- The effects of a pro-angiogenic, RGD-functionalized, nanofiber composite biomaterial on mesenchymal stem cell-mediated repair of the injured spinal cord
- From wheelchair to walking after spinal cord injury
Follow on Twitter
My TweetsSpinal Cord Injury Research and Science at Facebook
Categories
Archives
Tag Archives: Case Western Reserve University
NervGen looking to use their technology to revolutionize nerve damage treatment
NervGen Pharma (CVE:NGEN) President and CEO Ernest Wong sat down with Steve Darling from Proactive Investors Vancouver to talk about the pharma company that has technology that hopes to regenerate nerve damage, that damage can be spinal cord or peripheral. … Continue reading
Posted in Regenerative Medicine, spinal cord injury research, Uncategorized
Tagged Case Western Reserve University, Dr. Jerry Silver, NervGen Pharma Corp
Comments Off on NervGen looking to use their technology to revolutionize nerve damage treatment
NERVGEN PHARMA COMPLETES $10 MILLION INITIAL PUBLIC OFFERING
Vancouver, Canada. March 13, 2019 – NervGen Pharma Corp. (“NervGen” or the “Company”), a regenerative medicine company dedicated to creating innovative solutions for the treatment of nerve damage, today announced that it has completed its initial public offering (“IPO”) of … Continue reading
Posted in Ligand, Regenerative Medicine, spinal cord injury research
Tagged Case Western Reserve University, Dr. Jerry Silver, NervGen Pharma Corp
Comments Off on NERVGEN PHARMA COMPLETES $10 MILLION INITIAL PUBLIC OFFERING
Worldwide licensing agreement made on peptide developed in Silver laboratory at Case Western Reserve University
Read the Full Article at Globe Newswire. VANCOUVER, British Columbia, July 18, 2018 (GLOBE NEWSWIRE) — NervGen Pharma Corp. (“NervGen”), in Vancouver, and Case Western Reserve University (“Case Western Reserve”) in Cleveland have entered into an exclusive worldwide licensing agreement to research, develop and … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research
Tagged Brad Lang, Case Western Reserve University, Dr. Jerry Silver, NervGen Pharma Corp
Comments Off on Worldwide licensing agreement made on peptide developed in Silver laboratory at Case Western Reserve University
Modulation of the proteoglycan receptor PTPσ induces neuronal protease release to overcome Chondroitin Sulfate Proteoglycan inhibition of axon regeneration
Over the next few weeks I’ll post just a few of the interesting poster abstracts from the Society for Neuroscience conference held in Chicago this year. There’s too many to include them all, however, you’ll get a feel for where … Continue reading
Posted in Neuroscience Abstracts, Regenerative Medicine, spinal cord injury research
Tagged Bradley Lang, Case Western Reserve University, Dr. Jerry Silver
Comments Off on Modulation of the proteoglycan receptor PTPσ induces neuronal protease release to overcome Chondroitin Sulfate Proteoglycan inhibition of axon regeneration
Update on Experiments to Restore Function after Chronic SCI: Jerry Silver, PhD
The Silver lab is dedicated to the functional repair of the chronically injured spinal cord. We have developed a number of animal models to mimic both complete inury (transection) as well as severe contusive injury (with a small amount of … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, spinal cord injury research
Tagged Bradley Lang, Case Western Reserve University, Dr. Jerry Silver
Comments Off on Update on Experiments to Restore Function after Chronic SCI: Jerry Silver, PhD
The Case Builds: Novel SCI peptide also shows promise for heart attack and dangerous arrhythmias
Case Western Reserve’s chemical compound aimed at restoring spinal cord function may have an additional purpose: stopping potentially fatal arrhythmias after heart attack. Case Western Reserve neurosciences professor Jerry Silver long has believed that lessons learned over decades from spinal … Continue reading
Update on Experiments to Restore Function after Chronic SCI
Dr. Jerry Silver presented the latest information on their chronic research from his lab at Working 2 Walk 2014 in Seattle, WA. The Silver lab is dedicated to the functional repair of the chronically injured spinal cord and this research … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research
Tagged Bradley Lang, Case Western Reserve University, Dr. Jerry Silver, RPTP Sigma
Comments Off on Update on Experiments to Restore Function after Chronic SCI
SCI Peptide Therapy Research is Published in Nature Journal Today
Regeneration: Peptide therapy boosts recovery from spinal cord injury A new drug that encourages nerve growth is shown to help rats with spinal cord injury to regain movement and bladder control. The study, described in Nature this week, sheds light … Continue reading
Posted in Chronic Spinal Cord Injury Research, Neuroscience Abstracts, Regenerative Medicine, spinal cord injury research
Tagged Case Western Reserve University, Dr. Jerry Silver, RPTP Sigma
Comments Off on SCI Peptide Therapy Research is Published in Nature Journal Today
Modulation of CSPG Receptor Promotes Locomotor and Urinary Recovery – Dr. Jerry Silver
Dr. Silver presents findings from his lab’s discovery that peptide modulation of the CSPG receptor PTP allowed for remarkable recovery of hindlimb function, locomotor activity, and bladder control in 17 of 20 animals. (Courtesy presentation and video provided by Unite … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research
Tagged Case Western Reserve University, CSPG scar degradation, Dr. Jerry Silver, Protein Tyrosine Phosphatase-Sigma (PTPσ)
Comments Off on Modulation of CSPG Receptor Promotes Locomotor and Urinary Recovery – Dr. Jerry Silver